BL3H9B130358
BLD Pharmatech Co., Ltd.
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-((2-(pyrrolidin-1-yl)ethyl)amino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Iupac Name
13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-((2-(pyrrolidin-1-yl)ethyl)amino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl hydrogen carbonimidate
Inchi Code
1S/C34H50N4O8/c1-20-16-24-29(36-12-15-38-13-7-8-14-38)26(39)19-25(31(24)41)37-33(42)21(2)10-9-11-27(44-5)32(46-34(35)43)23(4)18-22(3)30(40)28(17-20)45-6/h9-11,18-20,22,27-28,30,32,36,40H,7-8,12-17H2,1-6H3,(H2,35,43)(H,37,42)
InChI key
MNMYYWFEPBLDKF-UHFFFAOYSA-N
储存温度
Keep in dark place, inert atmosphere, store in freezer, under -20C
Purity
98%
Country of Origin
CN
Shipping Temperature
Normal
Physical Form
Powder or crystals
Product Link
http://www.bldpharm.com/products/75747-23-8.html
Signal Word
Warning
Hazard Statements
Precautionary statements
MSDS
https://file.bldpharm.com/static/upload/prosds/bldsds/1355/SDS-BD01354761.pdf
法规信息
新产品
此项目有